PD-L1 Expression By Immunohistochemistry in Clear Cell Renal Cell Carcinoma Is Associated With High Tumor Stage and Nuclear Grade

被引:0
|
作者
Goodman, Steven [1 ]
Tamboli, Pheroze [1 ]
Rodriguez-Canales, Jaime [1 ]
Parra, Edwin [1 ]
Karam, Jose [1 ]
Wood, Christopher [1 ]
Rao, Priya [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
890
引用
收藏
页码:223A / 224A
页数:2
相关论文
共 50 条
  • [31] Implications of correlation between PBRM1 and PD-L1 expression in renal cell carcinoma, clear cell type
    Hwang, H.
    Choe, G.
    Lee, K. S.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S178 - S179
  • [32] Implications of Correlation Between PBRM1 and PD-L1 Expression in Renal Cell Carcinoma, Clear Cell Type
    Lee, Jieun
    Choe, Gheeyoung
    Lee, Kyu Sang
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 617 - 617
  • [33] Implications of Correlation Between PBRM1 and PD-L1 Expression in Renal Cell Carcinoma, Clear Cell Type
    Lee, Jieun
    Choe, Gheeyoung
    Lee, Kyu Sang
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 617 - 617
  • [34] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    M. Abbas
    S. Steffens
    M. Bellut
    H. Eggers
    A. Großhennig
    J. U. Becker
    G. Wegener
    A. J. Schrader
    V. Grünwald
    P. Ivanyi
    Medical Oncology, 2016, 33
  • [35] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    Abbas, M.
    Steffens, S.
    Bellut, M.
    Eggers, H.
    Grosshennig, A.
    Becker, J. U.
    Wegener, G.
    Schrader, A. J.
    Gruenwald, V.
    Ivanyi, P.
    MEDICAL ONCOLOGY, 2016, 33 (07)
  • [36] Loss of Nuclear BAP1 Expression s Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma
    Wi, Young Chan
    Moon, Ahrim
    Jung, Min Jung
    Kim, Yeseul
    Bang, Seong Sik
    Fang, Kiseok
    Paik, Seung Sam
    Shin, Su-Jin
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (06) : 378 - 385
  • [37] PD-L1 expression analysis of circulating tumor cells in advanced renal cell carcinoma
    Nagata, Masayoshi
    Kanayama, Mayuko
    Nagaya, Naoya
    Horie, Shigeo
    CANCER SCIENCE, 2018, 109 : 970 - 970
  • [38] Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)
    Bialek, Joanna
    Yankulov, Stefan
    Kawan, Felix
    Fornara, Paolo
    Theil, Gerit
    BIOMEDICINES, 2022, 10 (12)
  • [39] Comparing the performance of three PD-L1 antibodies for PD-L1 expression in renal cell carcinoma
    Park, S.
    Wi, Y. C.
    Shin, S.
    Jang, K.
    VIRCHOWS ARCHIV, 2019, 475 : S181 - S182
  • [40] Immunohistochemical study of PD-L1 and CD8 in clear cell renal cell carcinoma
    Azueta, A.
    Marcos Gonzalez, S.
    Hoz Fernandez, J.
    Grande Gozalez, L.
    Diaz Garcia, M. P.
    Freire Salinas, J.
    Garcia Arranz, M. P.
    Rodriguez Villar, D.
    Gomez-Roman, J.
    VIRCHOWS ARCHIV, 2020, 477 : S156 - S156